Stage IIIA Bladder Cancer AJCC v8

17 clinical trials · Condition

Record	Firm	Date
Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma (NCT04940299)	M.D. Anderson Cancer Center	2021-09-23
Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies (NCT04902040)	M.D. Anderson Cancer Center	2021-04-14
Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer (NCT04383743)	University of Washington	2020-11-24
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes (NCT04501913)	City of Hope Medical Center	2019-12-24
Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer (NCT03775265)	National Cancer Institute (NCI)	2019-06-03
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study (NCT06350734)	Mayo Clinic	2018-10-12
Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer (NCT03617913)	Mayo Clinic	2018-09-19
Pembrolizumab in Treating Patients With Bladder Cancer Undergoing Radical Cystectomy (NCT03319745)	M.D. Anderson Cancer Center	2018-01-11
Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer (NCT00749892)	M.D. Anderson Cancer Center	2008-06-10

Every clearance here is in the API, with alerts when new ones post.